NFG
LJPC

Next Financial Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Next Financial Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,750
Closed -$26K – 2735
2014
Q3 		$26K Buy
+2,750
New +$27.4K 0.01% 1278

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Next Financial Group's LJPC Position: Q4 2014 in Review

Next Financial Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2014, closing a stake of 2,750 shares — an estimated $26K sold.

Next Financial Group first reported a position in LJPC in Q3 2014 and held it in 1 quarter. The position peaked at $26K in Q3 2014. 35 funds tracked by Wall St. Rank hold LJPC as of Q4 2014.

  • Next Financial Group reported no remaining La Jolla Pharmaceutical Company position as of Q4 2014 after selling out during the quarter.
  • Next Financial Group sold 2,750 La Jolla Pharmaceutical Company shares in Q4 2014, an estimated $26K.
  • Next Financial Group first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 1 quarter.
  • Next Financial Group's La Jolla Pharmaceutical Company position peaked at $26K in Q3 2014.
  • 35 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2014.

Based on Next Financial Group's 13F filing for Q4 2014, filed 10 Feb 2015.